Reducing radiation: Heart Institute model shows hope for new standards worldwide

October 29, 2012

Toronto, October 29, 2012 - The University of Ottawa Heart Institute (UOHI) is setting the stage in what could become a revolution in medical imaging in Canada as it announces striking results in radiation reduction for the diagnosis of cardiovascular disease. The announcement comes as UOHI is currently showcasing its expertise at the 2012 Canadian Cardiovascular Congress in Toronto.

As a result of an initiative that combines optimizing test protocols, state-of-the art equipment, and high-tech software, two-thirds of the Ottawa Heart Institute's Nuclear Cardiology patients are currently receiving half the radiation dosage that they would normally get. Radiation reduction techniques have been achieved across all types of radiation-based cardiac imaging--nuclear, CT and PET. The Heart Institute is one of only a handful of centres in Canada with the in-house expertise to evaluate and clinically apply such advances across these technologies. UOHI is confident that all of its patients will receive lower amounts of radiation, and even less by early next year.

The American Society for Nuclear Cardiology has challenged the nuclear cardiology community to reduce radiation exposure below 9 millisieverts (mSv) by 2014. The techniques being employed at the Heart Institute regularly reduce exposure to 5 mSv, and often much less, putting UOHI well ahead of the game. This figure has not bottomed out as efforts will continue to minimize radiation wherever possible.

"Our clinicians are taking a much more critical look at who they are testing with radioactive methods and making decisions based upon risk and necessity which will only expose patients to radiation who truly need the test," said Dr. Benjamin Chow, Co-Director of Cardiac Radiology at the University of Ottawa Heart Institute. These responsible practices, along with a judicious use of technology, could revolutionize cardiac imaging in Canada."

The benefits of this effort include reduced radiation dosages for patients, greater flexibility for tailoring tests for patients, and, in some cases, reduced demand placed on radioisotopes. For younger patients, for example, radiation exposure poses greater risks because they have more years in which cancer could develop. So minimizing their dosage is a high priority. In the case of older patients whose lives may be threatened by an immediate cardiac condition, the benefit would outweigh the small risk of developing cancer later in life.

UOHI also uses a combination of powerful and effective tools that enable better diagnosis of cardiovascular problems. The cadmium zinc telluride camera system used for nuclear imaging is a significant innovation and was implemented by Dr. Glenn Wells, Medical Physicist in Nuclear Cardiology. The Heart Institute was one of the first centres in the world with this technology in 2009, and it had a major impact on reducing radiation in perfusion SPECT scans, by far the most common cardiac imaging test.

The introduction of PET cameras in the late 1990s, which provide much more detailed imagery with much lower levels of injected isotopes, has also had an impact on reducing radiation exposure. The use of such cameras in Canada is still uncommon but increasing.

Software is another critical part of imaging, turning the scanner data into coherent two- or even three-dimensional pictures of what is found in a patient's body. The Heart Institute has helped commercial developers evaluate and improve new advanced software packages for both PET and SPECT scanners that maintain image quality while using less radioactive isotopes.

Over the years, radiation has become a concern for our society, yet often we do not realize the significant benefit of highly accurate diagnostic techniques which may require very low amounts of medical radiation. "Careful and appropriate selection of the right test for the right patient balancing benefit and risk enables optimal patient care," said Dr. Terrence Ruddy, Director of Nuclear Cardiology, University of Ottawa Heart Institute. Experts at the University of Ottawa Heart Institute have demonstrated the tremendous capabilities of these techniques, and the equally tremendous strides that have been made in applying them responsibly.
-end-
INFORMATION

Vincent Lamontagne
Senior Manager, Public Affairs
University of Ottawa Heart Institute
613-899-6760 (cell)
vlamontagne@ottawaheart.ca

University of Ottawa Heart Institute

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.